FDA Overhauls Its Purple Book
Searchable Biologics Database Is Welcomed By Biosimilars Industry
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.